文献速递肿瘤 PET/CT

PSMA PET能否检测原发性前列腺癌组织学PSMA表达的瘤内异质性?[68Ga]Ga-PSMA-11与[18F]PSMA-1007分析

Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-01-17

前瞻性纳入35例活检证实无转移且未接受干预的原发性前列腺癌患者,分别行[68Ga]Ga-PSMA-11(队列I,20例)或[18F]PSMA-1007(队列II,15例)PSMA PET-CT后行根治性前列腺切除术。最终分析32例,组织学PSMA表达与SUVmean和SUVmax显著相关,两种示踪剂队列间无显著差异。

要点

  • 组织学PSMA表达与SUVmean和SUVmax显著相关(p<0.001,p=0.001)。
  • 肿瘤面积大于400 μm²时H-Score与SUVmean/SUVmax呈近似线性相关(p<0.001)。
  • 强PSMA表达肿瘤区与PET的GTV重叠显著大于极低表达区(p<0.01),两示踪剂队列无显著差异(p=0.72)。

核心结论

  • PSMA PET with both [68Ga]Ga-PSMA-11 or [18F]PSMA-1007 is able to detect changes in histological PSMA expression within PCa lesions allowing biologically targeted radiotherapy.

研究设计与样本

  • 前瞻性纳入35例活检证实原发性前列腺癌、无转移证据且无既往干预的患者,队列I为20例接受[68Ga]Ga-PSMA-11,队列II为15例接受[18F]PSMA-1007,均行PSMA PET-CT后行根治性前列腺切除术,最终32例纳入分析。
  • 标本行离体CT扫描并组织学制备,在数字化全mount前列腺切片上手动定义不同形态的PCa区域,借助人工智能计算免疫组化PSMA表达的H-Score。
  • 将H-Score相似的PCa区域在离体CT上统一分割,与PSMA PET-CT共配准后计算PSMA表达与SUVmean和SUVmax的Spearman相关系数,并分析共配准肿瘤区域与PSMA PET中GTV的一致性。

主要发现

  • 对于组织学PCa区域,免疫组化PSMA表达与SUVmean和SUVmax显著相关(p < 0.001,p = 0.001)。
  • 组织学肿瘤面积大于400 μm²时,H-Score与SUVmean/SUVmax呈近似线性相关(p < 0.001)。
  • 共配准后,强PSMA表达肿瘤区域与PSMA PET中GTV的重叠显著大于极低PSMA表达肿瘤区域(p < 0.01)。
  • 两个示踪剂队列之间未发现显著差异(p = 0.72)。

临床怎么用

  • 作者认为,使用[68Ga]Ga-PSMA-11或[18F]PSMA-1007的PSMA PET能够检测前列腺癌病灶内组织学PSMA表达的变化,从而允许进行生物学靶向放疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Prostate-specific membrane-antigen positron emission tomography (PSMA PET) is a promising candidate for non-invasive characterization of prostate cancer (PCa). This study evaluated whether PET with tracers [68Ga]Ga-PSMA-11 or [18F]PSMA-1007 is capable to depict intratumour heterogeneity of histological PSMA expression. METHODS: Thirty-five patients with biopsy-proven primary PCa without evidence of metastatic disease nor prior interventions were prospectively enrolled. All patients underwent PSMA PET combined with computer tomography (CT) with either [68Ga]Ga-PSMA-11 (cohort I, 20 patients) or [18F]PSMA-1007 (cohort II, 15 patients) followed by radical prostatectomy. Specimens were scanned by ex-vivo CT and histologically prepared. On digitized whole-mount prostate sections, PCa areas with different morphologies were manually defined and H-Score of immunohistochemical PSMA expression was calculated with assistance by artificial intelligence (AI). PCa areas with similar H-Score were unified in segmentation on ex-vivo CT. After co-registration on PSMA PET-CT, Spearman's coefficients of PSMA expression to mean and maximum standardized uptake value (SUVmean and SUVmax) were calculated. Furthermore, the agreement of the co-registered tumour areas to gross tumour volume (GTV) in PSMA PET was analysed. RESULTS: Thirty-two patients were included in the final analysis. For histological PCa areas, immunohistochemical PSMA expression correlated significantly to SUVmean and SUVmax (p < 0.001, p = 0.001). An approximate linear correlation between H-Score and SUVmean / SUVmax was found for tumour areas larger than 400 μm² in histology (p < 0.001). Tumour areas with strong PSMA expression showed a significantly larger overlap to GTV in PSMA PET after co-registration than tumour areas with very low PSMA expression (p < 0.01). No significant differences were found between the two tracer cohorts (p = 0.72). CONCLUSION: PSMA PET with both [68Ga]Ga-PSMA-11 or [18F]PSMA-1007 is able to detect changes in histological PSMA expression within PCa lesions allowing biologically targeted radiotherapy.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Waibel PMA, Glavynskyi I, Fechter T, et al. Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007. Eur J Nucl Med Mol Imaging. 2025. PMID: 39821663. doi:10.1007/s00259-025-07078-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。